Search

IS BD RUNNING A MONOPOLY ON THE SAFETY SYRINGE MARKET? IN A LAWSUIT FILED AGAINST BD, ITS DISTRIBUTORS, AND GROUP PURCHASING ORGANIZATIONS, A GROUP OF HEALTHCARE PROVIDERS HAVE ACCUSED THE COMPANY OF ABUSING ITS MARKET POWER.

May 19, 2018
A group of healthcare providers is calling foul on BD, accusing the company of abusing its "extraordinary market power to require the use of oppressive, anti-competitive contracts that effectively force above-competitive prices on the market."
 
The group filed a lawsuit in the U.S. District Court for Southern Illinois against BD (Becton Dickinson), its distributors, and group purchasing organizations (GPOs). Premier Inc., Vizient, Cardinal Health, Owens & Minor, and Henry Schein are among the named defendants. According to the lawsuit, BD has monopolized the U.S. safety syringe market.
 
The wording of the complaint suggests that the underlying problem is the U.S. purchasing system for medical devices.